| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 08/11/2009 | US7572833 E.g., N-(4-fluorophenylsulfonyl)-L-valyl-L-leucinal stabilized with a lipid; improved absorption and penetration; treating ischemia, immune diseases, Alzheimer's disease, osteoporosis, brain disorders, eye diseases, osteoporosis |
| 08/11/2009 | US7572832 Non-hygroscopic L-carnitine salts |
| 08/11/2009 | US7572831 Composition containing chalcone |
| 08/11/2009 | US7572830 Acyloxyalkyl carbamate prodrugs, methods of synthesis and use |
| 08/11/2009 | US7572829 Such as p-hydroxy-m-methoxyphenylacrylic acid, 4-(3-methoxy-4-hydroxyphenyl)-2-oxo-but-3-en-1-yl ester; Alzheimer's disease |
| 08/11/2009 | US7572828 Identification of anti-HIV compounds inhibiting virus assembly and binding of nucleocapsid protein to nucleic acid |
| 08/11/2009 | US7572827 Administering bergapten; modulate the expression of genes for gamma-globin in the human cell line K562; genetic blood disorders |
| 08/11/2009 | US7572826 Thiophene-carboxamide derivatives and their use as inhibitors of the enzyme IKK-2 |
| 08/11/2009 | US7572825 4-(t-Butyldiphenylsiloxy)pentyl-p-toluene sulfonate; 2,2-[4-Biphenyl-5-(t-butyldiphenylsiloxy)pentyl)]-1,3-propanedithiane; osteoporosis, rheumatoid arthritis, cancer associated bone disease, Paget's disease, aseptic loosening of prosthetic implants; inflammation |
| 08/11/2009 | US7572824 Methods for minimizing thioamide impurities |
| 08/11/2009 | US7572823 5-Chloro-6-fluoro-1H-indole-7-carboxylic acid [2-(3-trifluoromethoxy-phenyl)-ethyl]-(4-trimethylsilanyl-benzyl)-amide; inhibitors of the cholesteryl ester transfer protein |
| 08/11/2009 | US7572822 Biaryl substituted triazoles as sodium channel blockers |
| 08/11/2009 | US7572821 1-(3,4,5-trimethoxy-phenyl)-5-(4-bromo-phenyl)-1H-[1,2,3]triazole; 1-(2-hydroxy-4-methoxy-5-(2,3-dihydro-benzo[1,4]dioxin-6-yl)-5-(4-bromo-phenyl)-1H-[1,2,3]triazole; inhibits tubulin polymerization in a cell; cancer |
| 08/11/2009 | US7572820 Chemical compounds |
| 08/11/2009 | US7572819 Compounds which potentiate glutamate receptor and uses thereof in medicine |
| 08/11/2009 | US7572818 2-pyridylethylbenzamide derivative |
| 08/11/2009 | US7572817 Carboxypeptidase U inhibitors; thrombosis, atherosclerosis, adhesions, dermal scarring, cancer, fibrotic conditions, inflammatory diseases; e.g. 2-[(6-Aminopyridin-3-yl)methyl]-3-mercapto-5-[3-(pyrrolidin-1-ylcarbonyl)phenyl]pentanoic acid |
| 08/11/2009 | US7572816 Therapeutic agents for the treatment of cancer, metabolic diseases and skin disorders |
| 08/11/2009 | US7572815 Amide derivative |
| 08/11/2009 | US7572814 Useful in causing mitotic arrest and cell death; (cis,trans)-1-cyclopentyl-4-phenyl-5-(phenylcarbonyl)(3-piperidyl)phenyl ketone |
| 08/11/2009 | US7572813 Cyclic amide derivative as monocyte chemotactic protein modulator; prevention and treatment of rheumatoid arthritis, multiple sclerosis, atherosclerosis and asthma; antiinflammatory agents; N-[2-[[(cis) -2-[[1- (4-Chlorophenyl)ethyl]amino]cyclohexyl]amino]-2-oxoethyl]-3-(trifluoromethyl)benzamide |
| 08/11/2009 | US7572812 Treating or preventing pain, UI, an ulcer, IBD, IBS, an addictive disorder, Parkinson's disease, parkinsonism, anxiety, epilepsy, stroke, a seizure, a pruritic condition, psychosis, a cognitive disorder, a memory deficit, restricted brain function, Huntington's chorea, amyotrophic lateral sclerosis |
| 08/11/2009 | US7572811 Immunosuppressant compounds and compositions |
| 08/11/2009 | US7572810 Alkene piperidine derivatives as antiviral agents |
| 08/11/2009 | US7572809 (1-Isopropyl-6-methoxy-isoquinolin-3-yl)-(5-methyl-1H-pyrazol-3-yl)-amine; (5-Cyclopropyl-1H-pyrazol-3-yl)-(1-isopropyl-6,7-dimethoxy-isoquinolin-3-yl)-amine; Aurora kinase inhibitors; cancer |
| 08/11/2009 | US7572808 2-substituted 7-aryl-[1,2,4]triazolo[4,3-c]pyrimidin-3(2H)-one; mitogen-activated protein kinase inhibitor; physiological and psychotropic effects including regulation of appetite, immunosuppression, analgesia, inflammation, emesis, anti-nocioception, sedation, and intraocular pressure |
| 08/11/2009 | US7572807 3-Cycloheptyl-8-((2,6-dichlorophenoxy)methyl)H-imidazo[1,5-a]pyridine; N-((3-((2,6-Dichlorophenoxy)methyl)pyridin-2-yl)methyl)cycloheptane-carboxamide; diabetes; cardiovascular diseases, Metabolic Syndrome, inflammatory diseases |
| 08/11/2009 | US7572806 PPAR active compounds |
| 08/11/2009 | US7572805 (+-)-cis-6-(Trifluoromethyl)-2,3,3a,4-tetrahydro-1H-pyrrolo[3,4-c]isoquinolin-5(9bH)-one hydrochloride; modulation of serotonin receptors; obesity, diabetes, atherosclerosis, dyslipidemia; anxiety, depression, obsessive compulsive disorder, panic disorder, psychosis, schizophrenia, sleep disorder |
| 08/11/2009 | US7572804 Macrolides |
| 08/11/2009 | US7572803 Hydrated crystalline esters of camptothecin |
| 08/11/2009 | US7572802 For central nervous system diseases, in particular Parkinson's disease, Extra Pyramidal Syndrome, restless legs syndrome and attention deficit hyperactivity disorder |
| 08/11/2009 | US7572801 Pyridopyrimidinone derivatives which are HM74A agonists |
| 08/11/2009 | US7572800 Administering anti-hepatitis B virus agents in combination or alternation such asbeta-2-hydroxymethyl-5-(5-fluorocytosin-1-yl-1,3-oxathiolane or a salt and one another antihepatitis B agent |
| 08/11/2009 | US7572799 Pyrazolo[4,3-d]pyrimidines as Phosphodiesterase Inhibitors |
| 08/11/2009 | US7572798 Combi-molecules having signal transduction inhibitory properties and DNA damaging properties |
| 08/11/2009 | US7572797 Amino substituted pyrazine derivatives for the treatment of pain |
| 08/11/2009 | US7572796 excitatory amino acid antagonists for treating neurodegenerative diseases as cerebrovascular diseases, epilepsy, schizophrenia, Alzheimer's disease, Parkinson's disease, Huntington's disease, cerebral ischaemia, infarction, psychoses; 6-{3-[4-(4-fluorobenzyl)-1-piperidyl]propyl}-1H-indole-3-carbonitrile |
| 08/11/2009 | US7572795 Pyrrolotriazine aniline prodrug compounds useful as kinase inhibitors |
| 08/11/2009 | US7572794 Anthranilamide pyridinureas as vascular endothelial growth factor (VEGF) receptor kinase inhibitors |
| 08/11/2009 | US7572793 Tau protein kinase 1 inhibitors; treatment for neurodegenerative disorders; Alzheimer's Disease, Parkinson's disease, Pick's Disease, vision defects; antiischemic, antidiabetic, anticarcinogenic, antitumor agents, antidepressants |
| 08/11/2009 | US7572792 2,4-dichloro-N-{[1- (propylsulfonyl)-3-pyridin-2- ylazetidin-3- yl]methyl}benzamide; neurological and psychiatric disorders associated with glycinergic or glutamatergic neurotransmission dysfunction |
| 08/11/2009 | US7572791 Long-term stability, extended delivery using a suitable reservoir; pumped or metered at a controlled rate; implantable or external pump device, pen style injection device; stable at physiologic temperatures for duration of therapeutic exposure; supply of therapeutically active material for up to 2 years |
| 08/11/2009 | US7572790 Biphenyl carboxylic amide p38 kinase inhibitors |
| 08/11/2009 | US7572789 Salts of potassium ATP channel openers and uses thereof |
| 08/11/2009 | US7572788 Compositions and methods relating to novel compounds and targets thereof |
| 08/11/2009 | US7572787 Substituted naphthalene sulfonamides |
| 08/11/2009 | US7572786 Substituted 1-piperidin-3-yl-4-piperidin-4-yl-piperazine derivatives and their use as neurokinin antagonists |
| 08/11/2009 | US7572785 Substituted imidazoles as cannabinoid receptor modulators |
| 08/11/2009 | US7572784 Inhibit Aurora kinase; cancer; 4-[9-Chloro-7-(2-fluoro-phenyl)-5H-benzo[c]pyrimido[4,5-e]azepin-2-ylamino]-N-(2-methylamino-ethyl)-benzamide; 9-Chloro-N-(4-{[3-(dimethylamino)azetidin-1-yl]carbonyl}phenyl)-7-(2-fluoro-6-methoxyphenyl)-5H-pyrimido[5,4-d][2]benzazepin-2-amine |
| 08/11/2009 | US7572783 Obesity; N-(1-benzyl-piperidin-4-yl)-2-(2,5-dioxo-7-phenoxy-1,2,3,5-tetrahydro-benzo[e][1,4]diazepin-4-yl)-3-methyl-butyramide; modulators of ghrelin receptor (GHSR) |
| 08/11/2009 | US7572782 Use of targeted oxidative therapeutic formulation in bone regeneration |
| 08/11/2009 | US7572781 Prodrugs for use as ophthalmic agents |
| 08/11/2009 | US7572780 chemical therapeutic agent is a sex steroid hormone ; |
| 08/11/2009 | US7572779 Improved oral bioavailability of 17 beta-estradiol by adminstering the lower alkanoate; contraceptives, hormone replacement therapy |
| 08/11/2009 | US7572778 recognize and bind the tubulin site: antitubulin; useful for treating pathological states which arise from or are exacerbated by cell proliferation as anticancer and/or antiangiogenic activity |
| 08/11/2009 | US7572777 Administering a phosphate ester of florfenicol that may be hydrolyzed to form free florfenicol, e.g., 1R,2S-1-(4-Methanesulfonylphenyl)-2-(2,2-dichloroacetylamino)-3-fluoropropyl]-di-tert-butyl phosphate to treat or prevent bacterial infections |
| 08/11/2009 | US7572776 N-(phosphonoalkyl)-amino acids, derivatives thereof and compositions and methods of use |
| 08/11/2009 | US7572775 Method of inhibiting intestinal polyps |
| 08/11/2009 | US7572774 Methods for treating glutamate cytotoxicity with beta-naphthoquinone compounds |
| 08/11/2009 | US7572773 Single dose fast dissolving azithromycin |
| 08/11/2009 | US7572770 Use of an interleukin 1 receptor antagonist and/or pyrrolidinedithiocarbamate for the treatment or prophylaxis of type 2 diabetes |
| 08/11/2009 | US7572764 Uses of chemically-modified cholinesterases for detoxification of organophosporus compounds |
| 08/11/2009 | US7572762 Materials and methods relating to the induction of apoptosis in target cells |
| 08/11/2009 | US7572633 Use of the adenoviral E2 late promoter |
| 08/11/2009 | US7572613 Drug delivery system for accelerated subcutaneous absorption |
| 08/11/2009 | US7572606 Biosyntheses of salinosporamide A and its analogs and related methods of making salinosporamide A and its analogs |
| 08/11/2009 | US7572605 1,2,3,tris(4-hydroxy-butyroyloxy)propane; enhance the uptake of the drug, deliver effective therapeutic doses in a time-delayed fashion, and target specific organs |
| 08/11/2009 | US7572469 Therapeutic lotion for dermatitis |
| 08/11/2009 | US7572463 Oral dosage forms |
| 08/11/2009 | US7572459 Prevention infections in humans, animals |
| 08/11/2009 | US7572446 Antagonists of HMG1 for treating inflammatory conditions |
| 08/11/2009 | US7572438 Mutant having uracil phosphoribosyl transferase activity |
| 08/11/2009 | US7572245 Application of a therapeutic substance to a tissue location using an expandable medical device |
| 08/11/2009 | CA2564377C 6-o-substituted ketolides having antibacterial activity |
| 08/11/2009 | CA2548834C Tamper resistant co-extruded dosage form containing an active agent and an adverse agent and process of making same |
| 08/11/2009 | CA2546660C Selective inhibitors of viral or bacterial neuraminidase |
| 08/11/2009 | CA2537410C Ophthalmic indazole comprising compositions for treating ocular hypertension |
| 08/11/2009 | CA2527933C Substituted 3-alkyl and 3-alkenyl azetidine derivatives |
| 08/11/2009 | CA2487033C Amide substituted xanthine derivatives with gluconeogenesis modulating activity |
| 08/11/2009 | CA2482551C 1-(4-piperidinyl) benzimidazolones as histamine h3 antagonists |
| 08/11/2009 | CA2476520C Long acting parasiticidal composition containing a salicylanilide compound, a polymeric species and at least one other anti-parasitic compound |
| 08/11/2009 | CA2470581C Antidiabetic formulation and method |
| 08/11/2009 | CA2449402C Substituted tetrahydroisoquinolines for use in the treatment of inflammatory diseases |
| 08/11/2009 | CA2448825C Pharmaceutical compositions of adsorbates of amorphous drug |
| 08/11/2009 | CA2422699C Compositions for treating diabetes |
| 08/11/2009 | CA2417590C Prophylactic or ameliorative agent for insulin resistance and/or obesity |
| 08/11/2009 | CA2417089C Palatable oral coenzyme q liquid |
| 08/11/2009 | CA2410273C Halogenated rhodamine derivatives and applications thereof |
| 08/11/2009 | CA2408535C Compositions comprising dendrimer complexes |
| 08/11/2009 | CA2395846C Diazepan derivatives or salts thereof |
| 08/11/2009 | CA2392013C Analgesic compositions containing buprenorphine in combination with naloxone, naltrexone or nalmefene |
| 08/11/2009 | CA2391539C Use of poly(diallylamine) polymers |
| 08/11/2009 | CA2382013C Pharmaceutical solutions of levosimendan |
| 08/11/2009 | CA2381339C Dietary supplement enhancing the muscular energy metabolism, comprising an alkanoyl carnitine and ribose |
| 08/11/2009 | CA2375378C Antilipemic combinations comprising hmg-coa reductase inhibitors and carnitines |
| 08/11/2009 | CA2368688C Novel inhibitors of formation of advanced glycation endproducts (age's) |
| 08/11/2009 | CA2367410C Novel process for the preparation of 1-phenyl-2-(2-piridyl)ethanamine |
| 08/11/2009 | CA2362385C Heterodiazinon compound |
| 08/11/2009 | CA2359772C Cyclic substituted fused pyrrolocarbazoles and isoindolones |